Department of Obstetrics and Gynecology, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Int J Gynaecol Obstet. 2023 Oct;163(1):154-157. doi: 10.1002/ijgo.14890. Epub 2023 May 23.
We aim to study gender representation among the different national gynecologic oncology (GO) societies' presidents over the past decade.
A cross-sectional study examining the period 2013-2022. The leadership positions in 11 GO societies in the USA (SGO), internationally (IGCS), Europe (ESGO), Australia (ASGO), Israel (ISGO), Japan (JSGO), Asia-Oceania (AOGIN), India (INSGO), Latin America (SLAGO), South Africa (SASGO), and Turkey (TRSGO) was studied. The proportion of leadership positions held by women was calculated and trends were evaluated.
Overall, the average rate of women's representation during the study period was 26.4%, and for the different organizations was: SASGO 70.0%, SGO 50.0%, ESGO 40.0%, ASGO 30.0%, INSGO 30.0%, and IGCS, ISGO, and SLAGO 20.0% each, TRSGO 10%, and no representation of women in JSGO and AOGIN. There was a significant decrease from 2013 to 2016 (63.6% to 9.1%) (P = 0.009) in women's representation as presidents of societies. From 2017 to 2022, there was no difference in women's representation (ranging from 9.1% to 36.4%) (P = 0.13).
This study demonstrates that women are significantly under-represented in leadership positions in GO professional societies; however, in South Africa and the USA their representation in the last decade was close to equality.
研究过去十年中不同国家妇科肿瘤学（GO）学会主席的性别代表性。
这是一项横断面研究，研究时间为 2013 年至 2022 年。研究了美国（SGO）、国际（IGCS）、欧洲（ESGO）、澳大利亚（ASGO）、以色列（ISGO）、日本（JSGO）、亚大地区（AOGIN）、印度（INSGO）、拉丁美洲（SLAGO）、南非（SASGO）和土耳其（TRSGO）等 11 个 GO 学会的领导层职位。计算了女性担任领导职务的比例，并评估了趋势。
总体而言，研究期间女性代表率的平均值为 26.4%，不同组织的情况如下：SASGO 为 70.0%，SGO 为 50.0%，ESGO 为 40.0%，ASGO 为 30.0%，INSGO 为 30.0%，IGCS、ISGO 和 SLAGO 各为 20.0%，TRSGO 为 10.0%，JSGO 和 AOGIN 没有女性代表。女性担任学会主席的比例从 2013 年至 2016 年显著下降（63.6%降至 9.1%）（P=0.009）。从 2017 年至 2022 年，女性代表比例没有差异（范围为 9.1%至 36.4%）（P=0.13）。
本研究表明，女性在妇科肿瘤学专业学会的领导层中代表性严重不足；然而，在南非和美国，她们在过去十年中的代表性接近平等。
